Experimental once-daily drug doubles survival rates for pancreatic cancer patients
By
Stephanie Sy, Karina Cuevas, Katie Marlow
Summary
An experimental once-daily drug shows promising results in treating pancreatic cancer, doubling survival rates by slowing disease progression. Dr. Rachna Shroff from the University of Arizona Comprehensive Cancer Center discusses this breakthrough after decades of research into one of the deadliest cancers.
Source
bskyExperimental once-daily drug doubles survival rates for pancreatic cancer patientsto.pbs.orgKey quotes
· 3 pulledA medical breakthrough in the fight against pancreatic cancer is showing promising results after decades of research.
The experimental drug, taken once a day, extends patients' lives by slowing the progression of one of the deadliest cancers.
Dr. Rachna Shroff, associate director of clinical investigations at the University of Arizona Comprehensive Cancer Center, joins Stephanie Sy for more.
You might also wanna read
Daily pill daraxonrasib doubles survival in advanced pancreatic cancer, clinical trial shows
A clinical trial has shown that a daily pill called daraxonrasib can double survival time for patients with advanced pancreatic cancer, one
theguardian.com·1mo ago
Promising pancreatic cancer drug may unlock new class of treatments targeting cancer's master switch
The article discusses a promising new drug that targets pancreatic tumors and may have revealed a "master switch" for cancer. The treatment
economist.com·17d ago
Spanish Researchers Develop Breakthrough Therapy Protocol for Pancreatic Cancer Treatment
Spanish researchers have developed a new therapy protocol that could revolutionize pancreatic cancer treatment. Pancreatic cancer is notorio
nypost.com·4mo ago
Mitesh Borad, M.D., an oncologist at Mayo Clinic in Arizona, was part of the research for a new drug proven to give pancreatic cancer patients more time. He speaks on pancreatic cancer, risk factors a
consent.youtube.com
Mitesh Borad, M.D., an oncologist at Mayo Clinic in Arizona, was part of the research for a new drug proven to give pancreatic cancer patients more time. He speaks on pancreatic cancer, risk factors a
consent.youtube.comMitesh Borad, M.D., an oncologist at Mayo Clinic in Arizona, was part of the research for a new drug proven to give pancreatic cancer patients more time. He speaks on pancreatic cancer, risk factors a
consent.youtube.com
Comments
Sign in to join the conversation.
No comments yet. Be the first.